Michael P. Conlon

Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Christopher L. Cioffi, Nicoleta Dobri, Emily Freeman et al. · Journal of Medicinal Chemistry · 2014 · 51 citations · Full text

Using Alice 2.0 as a first language

Paul Mullins, Deborah Whitfield, Michael P. Conlon · 2009 · 45 citations

Lead Optimization toward Proof-of-Concept Tools for Huntington’s Disease within a 4-(1<i>H</i>-Pyrazol-4-yl)pyrimidine Class of Pan-JNK Inhibitors

John Wityak, Kevin F. McGee, Michael P. Conlon et al. · Journal of Medicinal Chemistry · 2015 · 38 citations

Molecular Biology, Pharmacotherapy, Proof-of-concept Tools +22

Bicyclic [3.3.0]-Octahydrocyclopenta[<i>c</i>]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease

Christopher L. Cioffi, Bóglárka Rácz, Emily Freeman et al. · Journal of Medicinal Chemistry · 2015 · 32 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Ocular Disease +12

Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis

Christopher L. Cioffi, Bóglárka Rácz, András Váradi et al. · Journal of Medicinal Chemistry · 2019 · 27 citations · Full text